Collected Notes
Brian Locke

COPD

Inhalers

Triple Inhalers

No increase in exacerbation risk for patients stable on triple inhalers (who do not have asthma or eosinophils over 300) to take off the ICS

  • this is advantageous due to increased risk of severe pneumonia
  • example of Pharmd led de-prescribing initiative: https://www.atsjournals.org/doi/full/10.1513/AnnalsATS.202007-871RL